We performed a post hoc analysis of data pooled from three randomized , placebo - and active-controlled , phase III studies of tapentadol ER for managing chronic osteoarthritis knee ( NCT@ , NCT@ ) or low back ( NCT@ ) pain ( @-week , double-blind treatment period ) .